Clinton's Science Adviser Faces Array Of Challenges

During 13 years as director of the Office of Technology Assessment, the job of John H. Gibbons--President Bill Clinton's choice as White House science adviser--was largely a balancing act. He had to provide Congress with independent, authoritative analysis of technical and scientific questions while treading gingerly amid divergent political views, bureaucratic turf battles, and special-interest "stakeholders." Washington observers familiar with OTA's track record give Gibbons high marks for

| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

During 13 years as director of the Office of Technology Assessment, the job of John H. Gibbons--President Bill Clinton's choice as White House science adviser--was largely a balancing act. He had to provide Congress with independent, authoritative analysis of technical and scientific questions while treading gingerly amid divergent political views, bureaucratic turf battles, and special-interest "stakeholders."

Washington observers familiar with OTA's track record give Gibbons high marks for leading the agency through potential minefields--including nuclear power and other environmentally sensitive energy issues, Star Wars missile defense research, genetic engineering, electronic surveillance, and health care policy. In the face of controversy, OTA's role has been not to take sides, but instead to prepare comprehensive, dispassionate assessments of the available data, and then offer a balanced selection of possible policy options.

Characteristically, Gibbons's initial public remarks after being appointed by Clinton have also been carefully balanced.

"Our security and prosperity depend, as ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Barton Reppert

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo